Cargando…

The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis

OBJECTIVES: This study aims to investigate the effects of fluoroscopy-guided sacroiliac joint steroid injection in patients with acute bilateral sacroiliitis diagnosed with axial spondyloarthritis (axSpA) and how those injections affect the current need for nonsteroidal anti-inflammatory drug (NSAID...

Descripción completa

Detalles Bibliográficos
Autores principales: KOKAR, Serdar, KAYHAN, Önder, ŞENCAN, Savaş, GÜNDÜZ, Osman Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140859/
https://www.ncbi.nlm.nih.gov/pubmed/34046572
http://dx.doi.org/10.46497/ArchRheumatol.2021.8043
_version_ 1783696260613537792
author KOKAR, Serdar
KAYHAN, Önder
ŞENCAN, Savaş
GÜNDÜZ, Osman Hakan
author_facet KOKAR, Serdar
KAYHAN, Önder
ŞENCAN, Savaş
GÜNDÜZ, Osman Hakan
author_sort KOKAR, Serdar
collection PubMed
description OBJECTIVES: This study aims to investigate the effects of fluoroscopy-guided sacroiliac joint steroid injection in patients with acute bilateral sacroiliitis diagnosed with axial spondyloarthritis (axSpA) and how those injections affect the current need for nonsteroidal anti-inflammatory drug (NSAID) usage. PATIENTS AND METHODS: We retrospectively evaluated 43 patients (28 males, 15 females; mean age, 31.7±6.3 years; range, 18 to 44 years) fulfilling the Assessment of SpondyloArthritis international Society 2009 criteria for axSpA between June 2015 and May 2016. One group included 22 patients (injection group) treated with sacroiliac joint steroid injection (triamcinolone acetonide) and the other group included 21 patients (non-injection group) not receiving the injection. All 43 patients in both groups were treated with indomethacin peroral. Pre-treatment, first week and first, third and sixth month follow-up examinations were evaluated. RESULTS: A ≥50% reduction in the numeric rating scale score compared with the baseline was considered as significant pain relief. The mean pain relief rates in patients receiving injections were higher at all inspections. This difference was statistically significant at first week (p<0.05). When groups were compared, no difference was found in the Bath Ankylosing Spondylitis Disease Activity Index scores (p>0.05). There was no statistically significant difference between the two groups when indomethacin dose was evaluated cumulatively for six months (p>0.05). CONCLUSION: Fluoroscopy-guided sacroiliac joint steroid injections can be recommended in patients with active sacroiliitis, particularly in those with severe axial pain, for rapid analgesia in the initial term. It was concluded that steroid injections applied to the sacroiliac joint did not affect disease activity. It is noteworthy that there is a trend to reduce the use of NSAIDs in patients receiving these injections, although it does not make a statistically significant difference in the long term.
format Online
Article
Text
id pubmed-8140859
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Turkish League Against Rheumatism
record_format MEDLINE/PubMed
spelling pubmed-81408592021-05-26 The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis KOKAR, Serdar KAYHAN, Önder ŞENCAN, Savaş GÜNDÜZ, Osman Hakan Arch Rheumatol Original Article OBJECTIVES: This study aims to investigate the effects of fluoroscopy-guided sacroiliac joint steroid injection in patients with acute bilateral sacroiliitis diagnosed with axial spondyloarthritis (axSpA) and how those injections affect the current need for nonsteroidal anti-inflammatory drug (NSAID) usage. PATIENTS AND METHODS: We retrospectively evaluated 43 patients (28 males, 15 females; mean age, 31.7±6.3 years; range, 18 to 44 years) fulfilling the Assessment of SpondyloArthritis international Society 2009 criteria for axSpA between June 2015 and May 2016. One group included 22 patients (injection group) treated with sacroiliac joint steroid injection (triamcinolone acetonide) and the other group included 21 patients (non-injection group) not receiving the injection. All 43 patients in both groups were treated with indomethacin peroral. Pre-treatment, first week and first, third and sixth month follow-up examinations were evaluated. RESULTS: A ≥50% reduction in the numeric rating scale score compared with the baseline was considered as significant pain relief. The mean pain relief rates in patients receiving injections were higher at all inspections. This difference was statistically significant at first week (p<0.05). When groups were compared, no difference was found in the Bath Ankylosing Spondylitis Disease Activity Index scores (p>0.05). There was no statistically significant difference between the two groups when indomethacin dose was evaluated cumulatively for six months (p>0.05). CONCLUSION: Fluoroscopy-guided sacroiliac joint steroid injections can be recommended in patients with active sacroiliitis, particularly in those with severe axial pain, for rapid analgesia in the initial term. It was concluded that steroid injections applied to the sacroiliac joint did not affect disease activity. It is noteworthy that there is a trend to reduce the use of NSAIDs in patients receiving these injections, although it does not make a statistically significant difference in the long term. Turkish League Against Rheumatism 2021-01-14 /pmc/articles/PMC8140859/ /pubmed/34046572 http://dx.doi.org/10.46497/ArchRheumatol.2021.8043 Text en Copyright © 2020, Turkish League Against Rheumatism https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Article
KOKAR, Serdar
KAYHAN, Önder
ŞENCAN, Savaş
GÜNDÜZ, Osman Hakan
The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
title The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
title_full The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
title_fullStr The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
title_full_unstemmed The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
title_short The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis
title_sort role of sacroiliac joint steroid injections in the treatment of axial spondyloarthritis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140859/
https://www.ncbi.nlm.nih.gov/pubmed/34046572
http://dx.doi.org/10.46497/ArchRheumatol.2021.8043
work_keys_str_mv AT kokarserdar theroleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT kayhanonder theroleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT sencansavas theroleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT gunduzosmanhakan theroleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT kokarserdar roleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT kayhanonder roleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT sencansavas roleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis
AT gunduzosmanhakan roleofsacroiliacjointsteroidinjectionsinthetreatmentofaxialspondyloarthritis